The recognition that obstructive disease of the epicardial coronary arteries, causing ischaemic heart disease, can be treated with a percutaneous coronary intervention (PCI) has been a major discovery in cardiology in the last 40 years contributing, in particular, to the reduction of mortality associated to acute myocardial infarction (AMI)....
-
2019 (v1)PublicationNeoatherosclerosis after drug-eluting stent implantation: a novel clinical and therapeutic challengeUploaded on: April 14, 2023
-
2018 (v1)Publication
Background: Superficial erosion currently causes at least one-third of acute coronary syndromes (ACS), and its incidence is increasing. Yet, the underlying mechanisms in humans are still largely unknown. Objectives: The authors sought to assess the role of hyaluronan (HA) metabolism in ACS. Methods: Peripheral blood mononuclear cells were...
Uploaded on: April 14, 2023 -
2020 (v1)Publication
To evaluate the safety and efficacy of the Orsiro sirolimus-eluting stent (Biotronik) in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention (pPCI). Specific drug-eluting stent (DES) platforms might influence pPCI success rate in the mid-to-long term. Orsiro, a hybrid sirolimus DES with...
Uploaded on: January 31, 2024 -
2021 (v1)Publication
No description
Uploaded on: March 27, 2023